Humana Inc. $HUM Shares Sold by Russell Investments Group Ltd.

Russell Investments Group Ltd. lowered its stake in Humana Inc. (NYSE:HUMFree Report) by 5.9% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 397,543 shares of the insurance provider’s stock after selling 24,931 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.33% of Humana worth $97,119,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Columbus Hill Capital Management L.P. boosted its stake in Humana by 24.7% in the 2nd quarter. Columbus Hill Capital Management L.P. now owns 158,154 shares of the insurance provider’s stock worth $38,665,000 after buying an additional 31,343 shares during the last quarter. J.W. Cole Advisors Inc. lifted its holdings in shares of Humana by 41.4% during the 2nd quarter. J.W. Cole Advisors Inc. now owns 2,310 shares of the insurance provider’s stock valued at $565,000 after acquiring an additional 676 shares in the last quarter. Clifford Capital Partners LLC purchased a new stake in shares of Humana in the second quarter worth about $9,901,000. Insigneo Advisory Services LLC boosted its holdings in Humana by 9.0% in the 2nd quarter. Insigneo Advisory Services LLC now owns 1,441 shares of the insurance provider’s stock worth $352,000 after acquiring an additional 119 shares during the period. Finally, Prudential Financial Inc. grew its holdings in Humana by 29.5% during the 2nd quarter. Prudential Financial Inc. now owns 169,936 shares of the insurance provider’s stock valued at $41,546,000 after purchasing an additional 38,744 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HUM. The Goldman Sachs Group lowered their price objective on Humana from $235.00 to $215.00 and set a “sell” rating for the company in a research note on Monday. Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a research report on Wednesday, October 8th. Truist Financial lowered their price target on Humana from $300.00 to $285.00 and set a “hold” rating on the stock in a report on Monday, November 10th. Bank of America boosted their target price on Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a report on Friday, October 10th. Finally, Piper Sandler dropped their price target on shares of Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a research report on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $295.94.

View Our Latest Stock Analysis on Humana

Humana Stock Up 3.3%

Shares of Humana stock opened at $245.73 on Thursday. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The company has a market cap of $29.55 billion, a P/E ratio of 18.86, a P/E/G ratio of 1.71 and a beta of 0.42. The stock has a 50-day moving average price of $263.71 and a 200 day moving average price of $256.78. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $315.35.

Humana (NYSE:HUMGet Free Report) last released its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, beating the consensus estimate of $2.95 by $0.29. Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm had revenue of $32.65 billion for the quarter, compared to analyst estimates of $31.99 billion. During the same quarter in the prior year, the business earned $4.16 EPS. The company’s revenue for the quarter was up 11.1% compared to the same quarter last year. As a group, analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.4%. Humana’s payout ratio is presently 33.18%.

About Humana

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Read More

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.